Entheon Biomedical Corp ENTBF:OTCQB

RT Quote | Exchange | USD
Last | 06/30/22 EDT
0.0343UNCH (UNCH)
52 week range
0.03 - 0.57
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0343
  • 52 Week High0.57
  • 52 Week High Date11/08/21
  • 52 Week Low0.03
  • 52 Week Low Date06/28/22

Key Stats

  • Market Cap3.21M
  • Shares Out59.09M
  • 10 Day Average Volume41,881.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-86.39

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0343
  • 52 Week High0.57
  • 52 Week High Date11/08/21
  • 52 Week Low0.03
  • 52 Week Low Date06/28/22
  • Market Cap3.21M
  • Shares Out59.09M
  • 10 Day Average Volume41,881.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-86.39

RATIOS/PROFITABILITY

  • EPS (TTM)-0.11
  • P/E (TTM)-0.31
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Entheon Biomedical Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Entheon Biomedical Corp. is a biotechnology research and development company. The Company focuses on developing a portfolio of Dimethyltryptamine (DMT) based psychedelic therapeutic products for treating addiction and substance use disorders. The Company’s DMT is advancing and sustaining new models of psychedelic-assisted therapy. The Company is developing a combination of genetic and predictive data analysis to ensure the safest psychedelic treatment possible. The Company is...
Address
211-3030 Lincoln Avenue
Coquitlam, BC
V3B 6B4
Canada